This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lucini, D. Articles by Pagani, M. Search for Related Content PubMed PubMed Citation Articles by Lucini, D. Articles by Pagani, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOSPORIN A Related Collections Cardiovascular Pharmacology Other hypertension CV surgery: transplantation, ventricular assistance, cardiomyopathy Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2000;35:1258.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Study of Arterial and Autonomic Effects of Cyclosporine in Humans

Daniela Lucini; Richard V. Milani; Hector O. Ventura; Mandeep R. Mehra; Franz Messerli; Massimo Pagani

From Centro di Ricerca sulla Terapia Neurovegetativa, Medicina Interna I, Ospedale "L. Sacco," Centro Ricerche Cardiovascolari, CNR, Università di Milano, Milano, Italy (D.L., M.P.); and the Department of Cardiology, Ochsner Medical Institutions, New Orleans, La (R.V.M., H.O.V., M.R.M., F.M.).

Correspondence to Massimo Pagani, MD, FACC, Medicina Interna I, Università di Milano, Via G.B. Grassi, 74, 20157 Milano, Italy. E-mail massimop{at}fisiopat.sacco.unimi.it

Abstract—Altered sympathetic activity and peripheral vascular function are suspected as a mechanism of the development of arterial hypertension in organ transplantation recipients treated with cyclosporine. We assessed whether cyclosporine might alter peripheral vascular properties or autonomic modulation of the sinus node and the vasculature during rest and standing. We examined 17 orthotopic heart transplantation recipients, 8 solid organ transplantation recipients, 17 patients with essential hypertension, and 42 normotensive control subjects. All except the normotensive control subjects were treated with a long-acting dihydropyridine calcium entry blocker; transplantation recipients also received cyclosporine-based immunosuppression. Radial artery compliance was reduced in patients with essential hypertension and in patients with heart and solid organ transplantation as compared with normotensive control subjects, with this reduction being more marked in heart transplantation recipients. At rest, R-R variance was lowest in heart transplantation recipients, denoting denervation. The spectral profile of both R-R and systolic blood pressure variability as well as the index of baroreflex gain was normal at rest in patients with solid organ transplantation. On standing, both transplantation groups demonstrated reduced responsiveness in markers of autonomic modulation. The decrease in arterial compliance in cyclosporine-induced hypertension seems to imply a degree of ventricular vascular uncoupling more apparent in heart transplantation recipients. These changes are associated with alterations in autonomic modulation that are evidenced by an orthostatic stimulus.

Key Words: autonomic nervous system • arterial mechanics • baroreflex • heart transplantation • compliance, arterial

This article has been cited by other articles:

				H. A. Shaltout and A. A. Abdel-Rahman Cyclosporine Induces Progressive Attenuation of Baroreceptor Heart Rate Response and Cumulative Pressor Response in Conscious Unrestrained Rats J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 966 - 973. [Abstract] [Full Text] [PDF]

				D. Goldsmith, R. MacGinley, A. Smith, and A. Covic How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? Nephrol. Dial. Transplant., June 1, 2002; 17(6): 965 - 969. [Full Text] [PDF]

				M. M. El-Mas, E. A. Afify, A. G. Omar, and F. M. Sharabi Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 346 - 354. [Abstract] [Full Text] [PDF]